Clinical trials are usually long term studies and it seems impossible to reach all required subjects at the same time. Performing interim analyses and monitoring results may provide early termination of trial after obtaining significant results. The aim of this study is comparing group sequential tests in respect to advantage of sample size reduction and early termination. In this study, 4 test types used in group sequential designs were compared with fixed sample size design test and each other. Comparisons were done according to two-sided tests for comparing two treatments. In this sense, 1080 models were performed. In models, 2 different Type I errors, 2 different powers, 5 different analysis groups, 6 different effect sizes and 9 different variances selections were considered. All test types increased the maximum sample size in different manner, compared with fixed sample size design. Each test had different critical values to reject H 0 hypothesis, at the same type I error rate and number of analyses conditions. Selection of test type used in group sequential designs depends on a few characteristics, as reducing sample size, early termination and detecting minimal effect size. Test performance is highly related with selected Type I error rate, power and number of analyses. In addition to these statistical characteristics, researchers should decide test type with respect to other trial conditions as the issue of trial, reaching subjects easy or not and importance of early termination.
Introduction
Clinical trials are designed to detect differences between treatments with a certain power and Type I error rate. Investigators should ensure to design clinical trials that contain adequate statistical power and sample size. It takes a long time to reach required subject number at the same time. Data are accumulated periodically course of the trial. Thus, it may take a few years to enroll enough subjects to meet determined sample size at the beginning of the trial. Particularly, in clinical trials which have death risk or any potential harm this may be more difficult and reaching required sample size may cause more increasing of trial time. Therefore, it is an important interest of investigators substantially to analyze accumulated data in specific intervals and evaluate results. Performing interim analyses and monitoring results may provide early termination of trial after obtaining significant results corresponding superiority, inferiority or equivalency of new treatment according to standard method.
Clinical trials can be classified in two groups in term of sample size, as fixed sample size designs and sequential designs [1] . In fixed sample designs, sample size is calculated at the beginning of the trial, and data are analyzed once after all required subjects enrolled. In sequential designs, sample size is calculated at the beginning of the trial similarly, but data are analyzed periodically by interim analyses as the trial going on and a final analysis is done at the finishing of the trial if required. Results of each interim analysis are evaluated to decide stopping or continuing the trial, and thereby the trial is monitoring [2] [3] [4] .
Sequential designs were initially developed for economical reasons. Early termination for a trial that have positive result means that a new product can be used sooner. If the trial have negative results, early termination ensures saving from sources. Sequential designs typically serve to savings in sample size, time and cost of the trial comparing with fixed sample size designs [5] [6] [7] .
There are several reasons for monitoring a trial, and decide to stopping or continuing it. In medical researches possible side effects, quality of life, cost or availability of alternative treatments can not be known at the beginning of the trial [5] . The most important reason is stop treating subjects with an ineffective treatment, when results show that test treatment is superior, inferior or equivalent to the standard treatment.
Sequential designs are categorized in three groups: fully sequential designs, group sequential designs and flexible sequential designs [1, 5] . In group sequential designs, interim analyses are done periodically at certain times determined at the beginning of the trial. Group sequential designs require determination of number and time of interim analyses at the beginning of the trial and remain constant. Interim analyses must be done by equal intervals [1] .
Group sequential designs based on the evaluation of results obtained interim analysis of data collected from each patient group with predetermined sample size [1] . There are many statistical criteria that controlled Type I error rate during periodic analyses. At each interim analysis test value calculated and compared with critical value of test. These critical values vary according to number of interim analyses and Type I error rate selected. Commonly used group sequential tests are suggested by Pocock and O'Brien & Fleming [6, 7] . They have been improved for common test statistics used to compare means, medians, proportions or survival curves. Group sequential designs required determination of number and time of interim analyses at the beginning of the trial and remain constant. Interim analyses must be done in equal intervals [1] .
The aim of this study is to evaluate four types (Pocock, O'Brien & Fleming, Wang & Tsiatis and Haybittle-Peto tests) of group sequential designs' tests used to compare means of two treatments comparatively. The comparisons were done in respect to advantage of sample size reduction, potential of early termination and detecting minimum differences between treatments at the same conditions.
Material and Methods

Two-Sided Tests for Comparing Two Treatments
In two sided hypothesis tests, the null hypothesis (H 0 ) referring "there is no statistically significant difference between two treatments" is controlled against the alternative hypothesis (H 1 ) referring "there is a statistically significant difference between two treatments". When treatments' means distributing normally with a known variance, the test statistic calculating is Z. In fixed sample size designs, when the value of Z statistic calculated is equal to or larger than a c value named "critical value" the null hypothesis (H 0 ) is rejected while it is accepted when the value of Z statistic is less. Determination of critical value based on the Type I error rate selected. Type I error is usually determined as 0.05 while 0.01 or 0.001 values are selected when the study has death risk, irreversible harms or potential risks. The formula of Z statistic to compare means of two treatments as A and B distributing normally with a known variance, and including n subjects is as follow [8, 9] :
Required sample size in each treatment group for comparing two independent groups is calculated as following way [5, [8] [9] [10] [11] :
Group Sequential Designs
In group sequential designs, number of analysis (K) and required sample size (m) in each group for each analysis is determined initially while two treatments are comparing. Total number of analyses in a group sequential design is K, consisting of K -1 interim analyses and a final analysis. The maximum subject number enroll to study is 2mK. The formula of Z k statistic to compare two means if A and B distributing normally with a known variance, and including 2m subjects is as follow [5, 9] :
Maximum sample sizes for each test types are differrent and calculated by multiplying n f in Equation (2.1.2) with a special factor R varying for each test type and each number of analysis.
In group sequential designs, since the number of statistical analyses is more than one, to protect total Type I error rate (α), Type I error rate (α k ) for each analysis should be determined by allocating the total Type I error rate (α) to each analysis. And the c k critical values are determined according to these Type I error rates (α k ) [1-3, 5,12] . Interim analyses are done after collecting data from each 2m subjects groups periodically and Z k test statistic is calculated for each analysis. When the value of Z k statistic calculated is equal to or larger than c k critical value the null hypothesis (H 0 ) is rejected and the trial is terminated, referring as "positive result". If the value of Z k statistic calculated is less than c k critical value, the trial continuing by adding a new 2m subjects group. If there is no positive result until final analysis and if still Z k < c k at the final analysis, than trial is terminated accepting the null hypothesis, referring as "negative result" [1, 3, 5, 9] . 
Pocock Test
    , , P f m R K n K     (2.2.2)
O'Brien & Fleming Test
The value of Z statistic after each interim analyses and final analysis is calculated in the same way with the formula given at Equation (2. [5, 9] .
Wang & Tsiatis Test
    , , , WT f m R K n K     (2.2.4)
Haybittle-Peto Test
Calculation of Z statistic after each interim analyses and final analysis is the same with other tests, with the formula given at Equation ( based on total Type I error rate (α), Type II error rate (β) and number of analyses (K). Subject number for each treatment in each interim analysis is calculated as follow [5, 9] .
Models
In Sample size calculations for large effect sizes were too small and critical values according to analysis group numbers can be calculated by iteration [5, 13] , so 1080 of these 10080 models were used. In these models, 2 different Type I errors (α), 2 different powers (1-β), 5 different number of analyses (K), 6 [5, 13] . Results are summarized with tables. bles 1-4) .
Results
All of the group sequential tests were required more sample size than the fixed sample size designs ( Tables  5-10 ). This increase was depending on effect size. Difference between sample sizes for group sequential tests and fixed sample size design was minimal when the effect size was large. Even they were similar beginning from 2.0 d  . 
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Copyright © 2012 SciRes. OJS 67 Table 7 . Sample sizes for α = 0.05, (1 -β) = 0.90, and d = 1.5. increases with number of analysis. So, the power of test achieves mainly later analyses [4, 5] .
Maximum sample size requiring in group sequential designs increases as the number of analyses increase. But, basic goal of group sequential designs is evaluating the advantage of early stopping through interim analysis [6, 7, 13] . It takes into consideration that, maximum sample size is only required when there is no positive result in all interim analyses and the trial goes on to the final analyses.
Critical values of group sequential tests in interim analyses were ordered in a different manner, changing for each interim analysis. In addition, order of tests in term The number of analyses performed is important as the test type used. In some conditions, 1 or 2 interim analyses may be effective for decreasing sample size, and generally 4 or 5 interim analyses are sufficient. Accordingly, for a group sequential design using O'Brien Fleming test, 10 K  interim analyses have been the optimum. In addition, for a group sequential design using Pocock test, 5 K  interim analysis seems unreasonable.
As a result, these four test types have several advantages and disadvantages. In a group sequential trial, decision of test type using to analysis the trial data, based on a few criteria: 1) whether early termination is important or not; 2) reducing sample size; 3) the issue of trial; 4) whether reaching the subject easy or not; 5) detecting minimal effect sizes. In the conditions that, reaching subjects is hard or studying smaller sample size because of high risk, the test which provides that detect smaller treatment differences at the first interim analyses can be preferred.
